An internally positioned signal can direct attachment of a glycophospholipid membrane anchor by unknown
An Internally Positioned Signal Can Direct Attachment 
of a Glycophospholipid Membrane Anchor 
Ingrid W. Caras 
Department of Immunobiology, Gencntech, Inc., South San Francisco, California 94080 
Abstract.  All known glycophosphatidylinositol (GPI)- 
anchored membrane proteins contain a COOH-ter- 
minal hydrophobic domain necessary for signalling an- 
chor attachment.  To examine the requirement that this 
signal be at the COOH terminus of the protein,  we 
constructed a chimeric protein,  DAFhGH, in which 
human growth hormone (hGH) was fused to the COOH 
terminus of decay accelerating  factor (DAF) (a GPI- 
anchored protein),  thereby placing the GPI signal in 
the middle of the chimeric protein.  We show that the 
fusion protein appears to be processed at the normal 
DAF processing site in COS cells, producing GPI- 
anchored DAF on the cell surface.  This result indi- 
cates that the GPI signal does not have to be at the 
COOH terminus to direct anchor addition,  suggesting 
that the absence of a hydrophilic COOH-terminal ex- 
tension (beyond the hydrophobic domain) is not a 
necessary requirement for GPI anchoring.  A  similar 
DAFhGH fusion, containing  an internal  GPI signal in 
which the DAF hydrophobic domain was replaced with 
the signal peptide of hGH, also produced GPI-anchored 
cell surface DAF. The signal for GPI attachment thus 
exhibits neither position specificity nor sequence spe- 
cificity. In addition, mutant DAF or DAFhGH constructs 
lacking an NH2-terminal signal peptide failed to pro- 
duce GPI-anchored protein,  suggesting that membrane 
translocation is necessary for anchor addition. 
iverse class  of integral  membrane  proteins  is  now 
known to be anchored to the plasma membrane by 
a  glycophosphatidylinositol (GPI) ~ structure cova- 
lently attached to the COOH terminus of the protein (for 
reviews  see Cross,  1990;  Low,  1989;  Ferguson and  Wil- 
lianas, 1988; Low and Saltiel,  1988). The GPI anchor con- 
tains phosphatidylinositol, carbohydrate,  and ethanolamine, 
and is thought to be preassembled in the ER (Masterson et 
al., 1989). Attachment  to the protein is directed by a signal 
at the COOH terminus of the protein (Caras et al.,  1987a) 
and  involves  a  processing  event  in  which  17-31 COOH- 
terminal  residues are removed from the nascent  chain  im- 
mediately before  or concomitant with anchor addition (Booth- 
royd et al.,  1981; Tse et al.,  1985),  the GPI anchor being 
added to the new COOH terminus.  Anchor addition  appar- 
ently takes place in the ER (Bangs et al., 1985, 1986; Fergu- 
son et al.,  1986),  after which the protein is transported to 
the cell surface via the Golgi apparatus. 
Although all GPI-anchored proteins presumably contain a 
signal for anchor attachment that is recognized by a common 
pathway, there is little  or no primary sequence homology. 
The only commonly observed feature  is the presence of a 
short hydrophobic domain (15-20 residues) at the COOH 
terminus of the protein (Low, 1989; Ferguson and Williams, 
1988). This hydrophobic domain is absolutely necessary (al- 
though insufficient) for anchor attachment,  deletion or short- 
ening of the hydrophobic  stretch leading to abolition of an- 
chor attachment and secretion of the protein (Caras et al., 
1989; Berger et al., 1988). Using the GPI-anchored protein 
decay  accelerating  factor  (DAF) t  (Davitz  et  al.,  1986; 
Medof et al.,  1986) as a model system to analyze the signal 
for  anchor  attachment,  we  have  previously  shown  that 
replacement of the COOH-terminal hydrophobic domain ei- 
ther with a signal peptide that normally functions in protein 
translocation,  or  with  a  random  hydrophobic  sequence, 
results  in efficient and correct processing, producing GPI- 
anchored  DAF  on  the  cell  surface  (Caras  and  Weddell, 
1989).  These observations suggest that the function of the 
COOH-terminal hydrophobic  domain in anchor attachment 
depends on its  hydrophobicity  rather  than  its  precise se- 
quence.  In addition  to the hydrophobic  domain, anchor at- 
tachment requires a second element believed to be the cleav- 
age/attachment  site  for the  anchor  (Caras  et  al.,  1989), 
generally located  10-12  residues NH2-terminal  to the hy- 
drophobic domain. Recent experiments have shown that Ser- 
319 (occurring  12 residues NH2-terminal  to the hydropho- 
bic domain) is the GPI-linked residue of DAF, indicating that 
28 residues are removed from the nascent chain during pro- 
cessing (Moran et al.,  1991). 
It has been suggested that a third feature is important for 
GPI attachment:  the absence of a hydrophilic  tail COOH- 
terminal  to the hydrophobic domain (Berger  et al.,  1989; 
1. Abbreviations used in this paper: DAF, decay accelerating factor; hGH, 
human growth hormone; GPI, glycophosphatidylinositol;  PIPLC, phospha- 
tidylinositol-specific  phospholipase C. 
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specificity of the GPI signal and asks,  by adding a  long 
hydrophilic  extension  to  the  COOH  terminus  of  DAF, 
whether an  internally positioned (as  opposed to  COOH- 
terminal) GPI signal can function in anchor attachment. We 
also examine whether translocation into the ER is necessary 
for anchor addition and ask if  the COOH-terminal hydropho- 
bic domain can function as a translocation signal in the ab- 
sence of an NH2-terminal signal peptide. 
Materials and Methods 
Materials 
mAbs against DAF were obtained from Dr. V. Nussenzweig of New York 
University (New York); purified rabbit antibody against human growth hor- 
mone (hGH) was provided by the Medicinal Analytical Chemistry Depart- 
ment (Genentech, Inc., South San Francisco, CA); IgG coupled to fluores- 
cein was from Cappel Laboratories (Cochranville, PA); [3I-l]ethanolamine 
was from Amersham Corp. (Arlington Heights, IL). Phosphatidylinositol- 
specific phospholipase C (PIPLC) purified from Bacillus thuringiensis was 
provided by Dr. M. G. Low of Columbia University (New York). Oligonu- 
cleotides were provided by M. Vasser,  P. Jhurani, and P. Ng (Genentech, 
Inc.). 
Recombinant Plasmids 
A DAFhGH fusion was constructed by cloning a full-length DAF cDNA 
(Caras et al., 1987 b) and a full-length hGH cDNA (DeNoto et al., 1981) 
in tandem into the M13 vector nap 18. Deletion mutagenesis (Zoller and 
Smith, 1982) was then used to delete unwanted 3' sequence (i.e., the 3' un- 
translated region) from the DAF cDNA and unwanted 5' sequence from the 
hGH cDNA, thereby creating an in-frame fusion in which the last residue 
of DAF was fused to the first residue of mature hGH. To construct DAF- 
Sig2hGH, a cDNA encoding A1 DAE which lacks the COOH-terminal hy- 
drophobic domain of DAF (Caras et al., 1989),  was used in place of wild- 
type DAF and the last residue of A1 DAF was fused to the first residue of 
the signal peptide of  pre-hGH. DAF-SiglhGH was constructed by fusing the 
previously described protein DAF-Sigl (Caras and Weddell, 1989),  con- 
taining residues -26 to -6 of the hGH signal peptide in place of the DAF 
COOH-terminal hydrophobic domain, to mature hGH as described above. 
The recombinant DNAs were verified by sequencing before being inserted 
into  a  mammalian  expression  vector  between  a  cytomegalovirus  en- 
hancer-promoter and an SV40 polyadenylation sequence (Eaton et al., 
1986).  Sig- mutants,  lacking the NH2-terminal signal peptide of DAF, 
were constructed by deletion mutagenesis in M13, verified by sequencing, 
and cloned into a mammalian expression vector as above. 
Transfections, Metabolic Labeling, 
and Immunoprecipitation 
COS cells were transfected using the DEAE dextran method as described 
by Selden (1987) using 2 tzg of plasmid DNA per 35-ram dish and DEAE- 
Dextran at 400/~g/ml.  Metabolic labeling of cells with [35S]methionine 
and analysis of proteins by immunoprecipitation was as previously de- 
scribed (Caras et al.,  1989;  Caras and Weddell, 1989). 
Immunofluorescent Labeling of Cells 
Immunofluorescent  labeling of  intact cells (cell surface labeling) or permea- 
bilized cells (internal labeling) was carried out essentially as described 
(Cat'as et al., 1987b) except that 0.5% Triton X-100/PBS was used to per- 
meabilize the cells. Cells were incubated with a mAb against DAF or a 
purified rabbit antibody against hGH, followed by fluorescein-conjugated 
goat anti-mouse or -rabbit antiserum (Cappel Laboratories). 
Results 
All  GPI-anchored membrane proteins  contain a  COOH- 
terminal hydrophobic domain required for anchor addition 
(Caras et al., 1989; Caras and Weddell, 1989; Berger et al., 
1988). To investigate whether this hydrophobic domain must 
be at, or very near, the COOH terminus, we constructed a 
fusion protein, DAFhGH, containing mature hGH fused in- 
frame to the COOH terminus of DAF (Fig. 1). This fusion 
effectively repositions the COOH-terminal hydrophobic do- 
main of DAF, placing it in the middle of the fusion protein 
between two large hydrophilic domains. The position of the 
cleavage/attachment site for the anchor (Ser-319)  (Moran et 
al., 1991), relative to the hydrophobic domain, remains un- 
changed. In addition, we constructed two deletion mutants, 
Sig-  DAF  and Sig-DAFhGH (Fig.  1)  in which the NH2- 
terminal signal peptide of DAF was removed from both wild- 
type DAF and the DAFhGH fusion protein. These deletion 
mutants address the questions: (a) Can the COOH-terminal 
hydrophobic domain serve as a membrane translocation sig- 
nal in addition to, or simultaneous with, triggering GPI an- 
chor attachment; and (b)  is translocation across the mem- 
brane of the ER necessary for GPI attachment? 
Immunoprecipitation Analysis 
The cDNAs  encoding these proteins were transiently ex- 
pressed in COS cells under control of the cytomegalovirus 
promoter. The cells were labeled with [35S]cysteine and the 
expressed proteins were immunoprecipitated from both the 
cell extracts and culture media using antibodies against ei- 
ther DAF or hGH.  As previously reported (Caras et al., 
1989), wild-type DAF is localized primarily in the cell lysate 
as a heterogenous, extensively glycosylated ~o70-kD mature 
form, and two ,x,40-kD,  partially glycosylated, precursor 
forms (Fig. 2, lane 2). In addition, the culture medium con- 
tains an ,~65-kD shed form (Fig. 2, lane 1/). The cell lysate 
from cells transfected with the DAFhGH expression vector 
contained the ~40- and ,'o70-kD DAF species, both of  which 
immunoprecipitated with  the  anti-DAF  antibody but  not 
with the anti-hGH antibody (Fig. 2, lanes 4 and 6), suggest- 
ing cleavage  of the fusion protein and release of the NH2- 
terminal DAF portion. The lysate also contained an *63-kD 
species that immunoprecipitated with both antibodies (anti- 
DAF and anti-hGH) and presumably represents uncleaved, 
partially or unglycosylated  fusion protein (predicted molecu- 
lar weight =  66 kD). A larger, '~80-kD species, probably 
a  glycosylated form of the uncleaved fusion protein,  was 
secreted into the culture medium and coprecipitated with an- 
tibodies against both DAF and hGH (Fig. 2, lanes 13 and 15). 
In addition, low levels of an ,~27-kD  hGH fragment, pre- 
sumably the cleaved COOH-terminal portion of the fusion 
protein, was detected in the cell lysate using anti-hGH an- 
tiserum (lane 6).  (The estimated molecular weight of this 
fragment,  which  should  contain  mature  hGH  plus  28 
COOH-terminal residues of DAE is ~26-kD). These data 
suggest that the DAFhGH fusion protein was in part cleaved 
to  yield an  NH2-terminal  DAF  fragment and  a  COOH- 
terminal hGH fragment, both of which remained cell as- 
sociated, and in part secreted as an intact fusion protein. 
Cells  expressing  Sig-DAFhGH,  which  lacks  an  NH2- 
terminal signal peptide, contained low levels ofa 60-kD pro- 
tein in the cell lysate. Although the molecular weight sug- 
gests that this species represents uncleaved fusion protein, it 
was detectable only with the anti-hGH antibody (lane  7). 
The slightly lower molecular weight of this 60-kD species 
relative to the 63-kD species generated by the DAFhGH fu- 
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Figure 1. (A) Schematic diagram showing DAFhGH fusion proteins and Sig- mutants. The unshaded areas represent the DAF coding se- 
quence. Shaded areas are as follows: ([]) signal peptide of DAF (residues -34 to -1); (,.) COOH-terminal hydrophobic domain of DAF 
(residues 331-347); (~) mature hGH coding sequence (residues 1-191); ([]) signal peptide of hGH (residues -26 to -1 in DAF-Sig2hGH). 
DAF-SiglhGH is similar to DAF-Sig2hGH but contains a truncated hGH signal peptide (residues -26 to -6) lacking the signal peptidase 
cleavage site. The boxed regions are expanded in B to show the actual sequences across the fusion junctions. (B) Expansion of the boxed 
areas in A, showing the amino acid sequence of the DAF COOH terminus and of the fusion junctions in the DAFhGH, DAF-Sig2hGH, 
and DAF-SiglhGH fusion proteins. The cleavage/attachment site of DAF (Ser-319) is indicated by an arrow. 
sion (lane 6) implies modification by glycosylation of  the lat- 
ter species only, in turn suggesting that the product of the 
Sig-DAFhGH construct was not translocated across the ER 
membrane. In addition, there was no evidence for secretion 
of this protein into the medium (lane 16), again suggesting 
that the internally positioned hydrophobic domain did not 
function as a translocation signal. No DAF protein was de- 
tectable  in  cells  transfected with  the  Sig-DAF  construct 
suggesting that if this protein was indeed expressed, it may 
have been rapidly degraded in the cytoplasm. Alternatively, 
incorrect folding  may have precluded recognition by  the 
anti-DAF  antibody,  which  is  known  to  be  conformation 
dependent and does not recognize reduced DAE Such con- 
formation dependence of the anti-DAF antibody might also 
explain why the  60-kD  Sig-DAFhGH  fusion protein was 
recognized only by the anti-hGH antibody and not by the 
anti-DAF antibody. 
Lanes 8 and 17 show a control transfection with the gene 
for chloramphenicol acetyl transferase (CAT), a cytoplasmic 
protein. The CAT protein was present exclusively in the cell 
lysate, indicating that there is no leakage of cytoplasmic pro- 
tein to the medium.  A  control transfection with the hGH 
gene (lanes 9 and 18) shows a secreted protein of lower mo- 
lecular weight than the COOH-terminal hGH fragment pro- 
duced by cleavage of the DAFhGH fusion (lane 6), suggest- 
ing that the DAFhGH fusion protein was cleaved within the 
DAF sequence (possibly at the normal anchor addition site) 
rather than at the fusion junction. (Mature hGH has a molec- 
ular weight of ,x,23  kD and electrophoreses with the dye 
front in this gel system). 
lmmunofluorescence Microscopy 
To determine the cellular localization of protein(s) encoded 
by the DAFhGH expression plasmid, the cells were exam- 
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from [~SS]cysteine-labeled  transfected COS 
cells using anti-DAF and anti-hGH antibod- 
ies. COS cells were labeled with [35S]cys- 
teine for 6 h, 24 h after transfection. Pro- 
teins were immunoprecipitated from both 
cell lysates (lanes 1-9) and the correspond- 
ing culture media (lanes 10-18) using either 
anti-DAF or anti-hGH antibodies as indi- 
cated. Lysate and media fractions thus rep- 
resent equal numbers of cells and the ex- 
posure times were equivalent. The DNAs 
used  for transfection are  indicated above 
each lane;  DNA was omitted from mock 
transfected control cultures. Additional con- 
trois  included transfection with RSV.CAT 
(to control for leakage of cytoplasmic pro- 
teins into the medium) followed by immu- 
noprecipitation with an anti-CAT antibody 
(lanes 8 and 17), and transfection with an 
hGH expression plasmid, followed by im- 
munoprecipitation with anti-hGH (lanes 9 
and 18). 
ined by immunofluorescence microscopy using  antibodies 
directed against either DAF or hGH. Cell-surface labeling 
of intact cells indicated that DAF derived from the DAFhGH 
fusion is on the cell surface (Fig. 3 b) as is wild-type DAF 
(Fig. 3 a). HGH was not detected on the cell surface (data 
not shown).  Staining of permeabilized cells with the anti- 
hGH antibody showed intense labeling of the ER and Golgi 
apparatus but not the plasma membrane (Fig. 3 e), whereas 
the  anti-DAF  antibody  stained  both  the  cell  boundaries 
(plasma membrane) and internal organeUes (Fig. 3, c and d). 
These data suggest that the cleaved DAF fragment produced 
from the DAFhGH fusion is targeted to the cell surface while 
the uncleaved fusion protein is confined to the organelles of 
the secretory pathway. No significant staining of either DAF 
or hGH could be detected in cells transfected with Sig-DAF 
or  Sig-DAFhGH (data  not  shown),  suggesting  either low 
expression levels (possibly because  of instability  of non- 
translocated proteins) or poor recognition by the antibodies 
due to incorrect folding in the cytoplasm. 
PIPLC Release Indicating the Presence 
of a GPI Anchor 
To determine whether the cell surface DAF produced from 
the DAFhGH fusion is anchored by a  GPI anchor,  trans- 
fected COS cells were incubated with purified PIPLC, and 
the levels of DAF in the incubation supernatants were mea- 
sured by an ELISA assay.  PIPLC treatment of cells trans- 
fected with  the  DAFhGH expression vector resulted in  a 
PIPLC-dependent release of DAF from the cell surface (Ta- 
ble I),  indicating that DAF molecules produced from the 
DAFhGH fusion are attached to the plasma membrane by a 
GPI membrane anchor. Shown for reference are the results 
obtained with control cells expressing either wild-type DAF, 
similarly showing PIPLC-dependent release, or a  secreted 
form ofDAF (A DAF; Caras et al., 1989) lacking a COOH- 
terminal hydrophobic domain, showing PIPLC-independent 
secretion into the incubation supernatant. Cells transfected 
with DAFhGH produced approximately fivefold less PIPLC- 
releasable DAF than cells expressing wild-type DAE  Al- 
though transient transfection efficiencies are variable (de- 
pending on factors such as the quality and purity of the DNA 
used), this result suggests that the internal GPI signal is rec- 
ognized less efficiently than the COOH-terminal signal. As 
expected, no DAF was detected in supernatants from cells 
transfected with the Sig- deletion mutants,  Sig-DAE  and 
Sig-DAFhGH (not shown). 
[3H]Ethanolamine Labeling 
To  verify that  the  cell  surface  DAF  produced  from the 
DAFhGH  fusion  is  anchored  by  a  GPI  membrane  an- 
chor, transfected COS cell were metabolically labeled with 
[3H]ethanolamine  and  analyzed  by  immunoprecipitation 
using an anti-DAF antibody. Cell lysates from cells trans- 
fected with DAFhGH contained a labeled •70-kD  doublet 
(Fig. 4, lane 4) that comigrated with authentic DAF (Fig. 4, 
lane 2), confirming that correctly processed GPI-anchored 
DAF is produced from the DAFhGH fusion. In addition, the 
media from cells expressing either DAF or DAFhGH con- 
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c) or the DAFhGH fusion (b, d, and e). To detect cell surface expression (a and b), cells were fixed but not permeabilized,  and labeled 
as described in Materials and Methods using an anti-DAF antibody. To detect intracellular protein (c, d, and e), cells were fixed and permea- 
bilized as described  in Materials  and Methods labeled with either an anti-DAF or anti-hGH  antibody as indicated. 
tained an ~68-kD ethanolamine-labeled species, believed to 
represent a released form of DAF resulting from a cleavage 
within the GPI anchor (Caras et al., 1989). The ~80-kD un- 
cleaved hGHDAF  fusion  protein  secreted  to  the  medium 
Table L DAF Levels Measured by ELISA 
in Supernatants  from Transfected  COS Cells Incubated 
With or Without PIPLC 
Addition 
Transfected DNA  None  PIPLC 
DAF (ng/ml) 
None  <0.09  <0.09 
Wild-type DAF  10  252 
DAFhGH  4  48 
AI DAF*  22  28 
* A1 DAF is a deletion mutant of DAF that lacks a COOH-terminal hydropho- 
bic domain, fails to become GPI-anchored, and is secreted (Caras et al., 1989). 
(Fig.  2)  was not labeled with  [3H]ethanolamine,  nor were 
any ethanolamine-labeled bands detected in cells expressing 
Sig-DAF or Sig-DAFhGH. 
An Internally Positioned Signal Peptide Can Direct 
GPI Attachment 
We have previously shown that a signal for protein secretion 
can direct GPI anchor attachment when positioned at the 
COOH terminus of DAF, in place of the DAF hydrophobic 
domain (Caras and Weddell,  1989).  To determine whether 
a signal peptide located internally within a protein can simi- 
larly direct GPI attachment, we constructed the fusion pro- 
tein DAF-Sig2hGH (Fig.  1) in which a DAF sequence lack- 
ing the COOH-terminal hydrophobic domain was fused to 
pre-hGH.  The  NH2-terminal  signal  peptide  of hGH  thus 
replaces the COOH-terminal hydrophobic domain of DAF 
and  is  followed by the  complete mature hGH  coding  se- 
quence. The position of the cleavage/attachment site relative 
to the hydrophobic signalling domain, remains unchanged. 
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cipitation of proteins in transfected  COS cells. COS cells 
transfected with DNAs as indicated were labeled over- 
night with [3H]ethanolamine  (200/~Ci per 35-ram dish). 
Cell lysates (lanes 1-5) and media (lanes 6-10) were ana- 
lyzed by immunoprecipitation using an anti-DAF anti- 
body. DNA was omitted from mock-transfected  controls. 
To eliminate potential complications caused by cleavage of 
the internal signal peptide by signal peptidase, a similar fu- 
sion, DAF-SiglhGH (Fig.  1), was constructed in which the 
signal  peptidase  cleavage  site  (residues  -5  to  -1)  was 
deleted from the hGH signal peptide, thus preventing possi- 
ble cleavage of the fusion protein near the fusion junction. 
This fusion protein is analogous to the previously described 
protein DAF-Sigl, containing a truncated hGH signal pep- 
tide in place of the DAF COOH-terminal hydrophobic do- 
main (Caras and Weddell, 1989), but the entire hGH coding 
region has now been added as a COOH-terminal extension. 
COS ceils were transfected with expression plasmids encod- 
ing DAF-Sig2hGH or DAF-SiglhGH, and then labeled with 
[35S]cysteine. The proteins were analyzed by immunopre- 
cipitation, revealing a pattern similar to that observed with 
the DAFhGH fusion (data not shown), suggesting that, like 
DAFhGH, these fusion proteins were in part cleaved to yield 
both DAF and hGH fragments, and in part secreted as intact 
fusion proteins. There was no significant difference in the 
polypeptides produced from the DAF-SiglhGH and DAF- 
Sig2hGH fusions, and the absence of a fragment correspond- 
ing to mature hGH in either the cell lysate or culture medium 
suggests that the internally positioned hGH signal peptide 
was not cleaved by signal peptidase. 
Immunofluorescent staining  of  nonpermeabilized  COS 
cells transfected with DAF-Sig2hGH or DAF-SiglhGH re- 
vealed that DAF (but not hGH) was expressed on the cell sur- 
face  (Fig.  5,  top),  data  shown only for  DAF-Sig2hGH). 
Staining of permeabilized cells indicated that hGH was pres- 
ent in the secretory pathway (the ER and Golgi apparatus 
were intensely stained; Fig. 5, bottom), but not on the plas- 
ma membrane whereas DAF could be detected on the plasma 
membrane as well as in these internal organelles (Fig.  5, 
middle). 
To determine whether cleavage of DAF-SiglhGH or DAF- 
Sig2hGH produces  GPI-anchored  DAF,  transfected COS 
cells were labeled with pH]ethanolamine and then analyzed 
by  immunoprecipitation.  The  DAF-SiglhGH  and  DAF- 
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transfected with DAF-Sig2hGH. Intact cells (fixed  but 
not permeabilized) were labeled with an anti-DAF an- 
tibody (top);  permeabilized cells were labeled with ei- 
ther anti-DAF (middle) or anti-hGh antibodies (bot- 
tom). Procedures were as described in Materials and 
Methods. 
Sig2hGH products (Fig.  6,  lanes 2  and 3) were compared 
with authentic DAF (lane 4) and DAF-Sig2 (lane 5), contain- 
ing a  COOH-terminal hGH signal peptide in place of the 
DAF hydrophobic domain (Caras and Weddell,  1989). All 
the cell lysates contained similar [3H]ethanolamine-labeled 
bands corresponding to the 40-kD precursor and ,,o70-kD 
mature  form of authentic  DAF,  indicating  that  the  DAF- 
SiglhGH and DAF-Sig2hGH fusions were processed at or 
near the normal DAF processing site,  giving rise to GPI- 
anchored cell surface DAE These results indicate that an in- 
ternally positioned signal peptide can function in GPI attach- 
ment, suggesting that the requirement for a COOH-terminal 
hydrophobic domain is neither sequence specific nor posi- 
tion specific. 
Discussion 
The Signal for GPI Attachment Does Not Have To Be 
at the COOH Terminus 
Previous reports have shown that GPI attachment is directed 
by a COOH-terminal signal consisting of  two elements: a hy- 
drophobic domain and a  cleavage attachment site,  located 
,~10-12 residues NH:-terminal to the hydrophobic domain 
(Caras et al.,  1989). In addition, it has been suggested that 
the absence of a hydrophilic (cytoplasmic) tail may be an im- 
portant feature of the GPI signal (Berger et al., 1980; Cross 
1990). In this report, we examined the requirement that the 
GPI signal be at the COOH terminus of the protein.  Our 
results show that repositioning of the GPI signal of DAF to 
the middle of a large hydrophilic fusion protein allows cor- 
rect processing, apparently at or near the normal processing 
site, producing authentic GPI-anchored DAF on the cell sur- 
face. The question as to whether the absence of a hydrophilic 
COOH-terminal tail is an important feature of the GPI sig- 
nal, has been controversial. The presence or absence of the 
21-amino acid cytoplasmic tail present in the transmembrane 
but not the GPI-anchored form of  the human IgG Fc receptor 
(FcqcRIII) is  apparently not the critical feature that deter- 
mines GPI anchoring, and molecules containing this short, 
COOH-terminal  extension  can  become  GPI  anchored 
(Lanier et al.,  1980; Kurosaki and Ravetch, 1989). On the 
other hand, replacement of  the COOH-terminal hydrophobic 
domain of placental  alkaline phosphatase  with  the  trans- 
membrane-cytoplasmic  domains of  vesicular stomatitis virus 
glycoprotein completely abolished GPI attachment, leading 
to the suggestion that the absence of a cytoplasmic tail may 
be important for GPI anchoring (Berger et al.,  1989). Our 
data now indicate that despite the presence of a  long hy- 
drophilic extension of 191 amino acids, DAF molecules can 
be targeted to the plasma membrane via a GPI anchor, sug- 
Caras Internal Signal Directing Glycophospholipid Anchor Attachment  83 Figure 6. [3H]Ethanolamine  labeling of COS ceils transfected with 
DAF-SiglhGH or DAF-Sig2hGH. Ceils were labeled with [3H]- 
ethanolamine and analyzed by immunoprecipitation using an anti- 
DAF antibody as described in Materials and Methods. The DNAs 
used for transfection are: DAF-SiglhGH, similar to DAF-Sig2hGH 
but containing a truncated hGH signal peptide lacking the signal 
peptidase cleavage  site (lane 2); DAF-Sig2hGH  (lane 3 ); wild-type 
DAF (lane 4); and DAF-Sig2, containing the signal peptide ofhGH 
in place of  the DAF COOH-terminal hydrophobic domain (lane 5). 
DNA was omitted from the mock-transfected control. 
gesting that the absence of a hydrophilic tail is not a critical 
feature of the GPI signal.  A fraction of these altered DAF 
molecules escape processing however and are secreted as in- 
tact fusion protein,  suggesting that an internal GPI signal 
may be recognized less  efficiently than a  COOH-terminal 
signal. 
All known GPI-anchored proteins examined to date con- 
tain hydrophilic extensions (beyond the COOH-terminal hy- 
drophobic domain) of no more than a few amino acids. Our 
results suggest that this may represent an evolutionary adap- 
tation rather than a  strict functional constraint.  Since the 
COOH-terminus of the nascent polypeptide is removed (and 
presumably degraded) during anchor addition, there may be 
little  advantage  to  synthesizing  more  than  the  minimum 
COOH-terminal sequence required to contain the GPI signal. 
The absence of  any detectable staining of  the plasma mem- 
brane when permeabilized cells were stained with an anti- 
hGH antibody suggests that intact fusion molecules were not 
held on the cell surface in a non-GPI-anchored form. This 
observation that uncleaved fusion molecules are  secreted 
rather than held in the plasma membrane as transmembrane 
proteins, suggests that the COOH-terminal hydrophobic do- 
main of DAF (17 amino acids) does not function as a mem- 
brane  anchor,  being  either insufficiently hydrophobic, or 
lacking additional stop-transfer signals. This implies that the 
hydrophobic domain functions as an actual recognition sig- 
nal for GPI attachment rather than as a transient membrane 
anchor, as has been suggested. 
An Internally Positioned Signal Peptide Can Direct 
GPI  Attachmen t 
We have previously shown that the COOH-terminal hydro- 
phobic domain of  DAF can be replaced with unrelated hydro- 
phobic sequences such as the hGH membrane translocation 
signal peptide, without affecting anchor addition (Caras and 
Weddell,  1989). Our present results show that this is also 
true for the internally positioned GPI signal. The hGH signal 
peptide for protein secretion effectively replaced the DAF 
hydrophobic domain when positioned in the middle of the 
hydrophilic DAFhGH fusion protein, indicating that the re- 
quirement for a hydrophobic domain in GPI attachment is 
neither sequence specific nor position specific. It is not un- 
reasonable to speculate that any internal hydrophobic do- 
main has the potential to act as a signal for GPI addition, one 
constraint being the requirement for a  recognizable cleav- 
age/attachment site located •10-12  residues NH2-terminal 
to the hydrophobic domain.  It is conceivable that the ac- 
cumulation of point mutations creating or deleting a  GPI 
cleavage/attachment site could interconvert genes encoding 
transmembrane or GPI-linked proteins. The closely related 
genes  for two forms of the Fc3,RIII  receptor (encoding a 
GPI-linked protein on neutrophils and a transmembrane pro- 
tein on natural killer cells and macrophages) could represent 
such  a  case.  Here,  a  single amino  acid change  near the 
COOH terminus has been shown to determine the mode of 
anchorage of the protein (Lanier et al.,  1989; Kurosaki and 
Ravetch,  1989). 
Membrane Translocation Appears To Be 
A Prerequisite for GPI Attachment 
DAF  or  DAFhGH  proteins  that  lacked  an  NH2-terminal 
signal peptide failed to produce GPI-anchored cell surface 
DAE  Deletion  of the  NHE-terminal  signal  peptide  from 
DAF  or the  DAFhGH fusion apparently prevented mem- 
brane  translocation  and  curtailed the  expression level of 
these proteins in COS cells, possibly because failure to be 
translocated resulted in rapid degradation in the cytoplasm. 
In addition, there was no evidence for incorporation of a GPI 
anchor (e.g., by [3H]ethanolamine labeling). These results 
suggest that the DAF hydrophobic domain, positioned either 
The Journal  of Cell Biology,  Volume 113, 1991  84 internally or at the COOH terminus, did not function as a 
translocation signal. Secondly, although negative results pre- 
clude a finn conclusion, it seems likely that membrane trans- 
location is required for GPI anchor attachment. 
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